tert-Butyl 3-(isopropylthio)azetidine-1-carboxylate

Catalog No. :
ACOXLB561
CAS No. :
2891597-54-7
Molecular Formula :
C11H21NO2S
Molecular Weight :
231.36

IUPAC Name:tert-butyl 3-(isopropylthio)azetidine-1-carboxylate

tert-Butyl 3-(isopropylthio)azetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$52.00Login to see priceIn stockInquiry
250mg95%$79.00Login to see priceIn stockInquiry
500mg95%$130.00Login to see priceIn stockInquiry
1g95%$208.00Login to see priceIn stockInquiry
5g95%$625.00Login to see priceIn stockInquiry
10g95%$1042.00Login to see priceIn stockInquiry
25g95%$2082.00Login to see priceIn stockInquiry
50g95%$3385.00Login to see priceInquiryInquiry
100g95%$5206.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(isopropylthio)azetidine-1-carboxylate
IUPAC Nametert-butyl 3-(isopropylthio)azetidine-1-carboxylate
Molecular FormulaC11H21NO2S
Molecular Weight231.36
SMILESCC(SC1CN(C1)C(OC(C)(C)C)=O)C
InChI KeyDCYNQBQDQFLEOU-UHFFFAOYSA-N
Synonymtert-butyl 3-isopropylsulfanylazetidine-1-carboxylate;1-Azetidinecarboxylic acid, 3-[(1-methylethyl)thio]-, 1,1-dimethylethyl ester
CAS No.2891597-54-7

Synthetic Route by SureRoute

1. ACOXLB561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHCXZ590 route compound structure diagram
    ACHCXZ590254454-54-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOXLB561 route product structure diagram
    ACOXLB5612891597-54-7 In Stock
Inquiry

2. ACOXLB561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOXLB561 route product structure diagram
    ACOXLB5612891597-54-7 In Stock
Inquiry

Comments (0)